Joan Wright

Safety and tolerability of putaminal <i>AADC</i> gene therapy for Parkinson disease

Chadwick W. Christine, Philip A. Starr, Paul Larson et al. · Neurology · 2009 · 424 citations · Full text

Identification and partial characterization of a low affinity metal-binding site in the light chain of tetanus toxin.

Joan Wright, Martine Pernollet, A. Reboul et al. · Journal of Biological Chemistry · 1992 · 68 citations · Full text

Light Chain, Toxinology, Biochemistry +13

Flow cytometric analysis of platelets from childrenwith the Wiskott‐Aldrich syndrome reveals defects in platelet development, activation and structure

John W. Semple, Katherine A. Siminovitch, Meera Mody et al. · British Journal of Haematology · 1997 · 61 citations

C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the mu-chain.

Joan Wright, Marc J. Shulman, David E. Isenman et al. · Journal of Biological Chemistry · 1990 · 41 citations · Full text

C1 Binding, Abnormal Glycosylation, Glycobiology +16

C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain.

Joan Wright, Marc J. Shulman, David E. Isenman et al. · Journal of Biological Chemistry · 1988 · 31 citations · Full text

C1 Binding, Molecular Biology, Cellular Physiology +17